Endocrine Research最新文献

筛选
英文 中文
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome. 散发性甲状腺髓样癌和家族性甲状腺髓样癌:关于表现和预后的单中心回顾性研究
IF 1.5 4区 医学
Endocrine Research Pub Date : 2024-08-01 Epub Date: 2024-10-17 DOI: 10.1080/07435800.2024.2344103
Antonio Prinzi, Veronica Vella, Agata Bosco, Alessandro Mirone, Marco Russo, Tommaso Piticchio, Guenda Di Benedetto, Giovanni Bartoloni, Francesco Frasca, Pasqualino Malandrino
{"title":"Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome.","authors":"Antonio Prinzi, Veronica Vella, Agata Bosco, Alessandro Mirone, Marco Russo, Tommaso Piticchio, Guenda Di Benedetto, Giovanni Bartoloni, Francesco Frasca, Pasqualino Malandrino","doi":"10.1080/07435800.2024.2344103","DOIUrl":"https://doi.org/10.1080/07435800.2024.2344103","url":null,"abstract":"<p><strong>Background: </strong>Medullary Thyroid Carcinoma (MTC) is a neuroendocrine tumor that arises from the thyroid C-cells. Most cases are sporadic (sMTC) while, approximately 25%, are hereditary (hMTC) due to germline mutations of REarranged during Transfection (RET) gene mutations and manifest in the framework of multiple endocrine neoplasia (MEN) 2A or 2B, or as pure familial MTC syndrome (FMTC).</p><p><strong>Objective: </strong>The aim of this study is to evaluate the clinical, histopathological, biochemical and outcome differences between sMTC and hMTC.</p><p><strong>Methods: </strong>Retrospective analysis of a consecutive series of 102 patients with histologically proven MTC diagnosed in the period between 2000 and 2022. For the analysis patients with MTC diagnosed during screening through genetic test were excluded.</p><p><strong>Results: </strong>Patients with hMTC had higher incidence of multifocal and bilateral MTC and younger age at diagnosis. We did not found differences on tumor stage at diagnosis between sMTC and hMTC, such as time to progression and rate of persistent and recurrent disease. At univariate analysis, factors associated with persistent and recurrent disease during follow-up in patients with sMTC were tumor size, extrathyroidal extension, presence of lymph node metastases at diagnosis, pre- and post-operative calcitonin, post-operative CEA; in patients with hMTC, features associated with persistent and recurrent disease were lymph node metastases, post-operative calcitonin and pre- and post-operative CEA values.</p><p><strong>Conclusion: </strong>Patients with hMTC and sMTC had similar histopathological characteristics and clinical outcome.</p>","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":"49 4","pages":"179-185"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Prediabetes and Risk, Mortality of Hepatocellular Carcinoma: A Meta-Analysis. 糖尿病前期与肝细胞癌的风险和死亡率之间的关系:一项 Meta 分析。
IF 1.5 4区 医学
Endocrine Research Pub Date : 2024-08-01 Epub Date: 2024-06-03 DOI: 10.1080/07435800.2024.2361160
Xin Ding, Li Deng, Chuan Cen, Yuyu Yang
{"title":"Association Between Prediabetes and Risk, Mortality of Hepatocellular Carcinoma: A Meta-Analysis.","authors":"Xin Ding, Li Deng, Chuan Cen, Yuyu Yang","doi":"10.1080/07435800.2024.2361160","DOIUrl":"10.1080/07435800.2024.2361160","url":null,"abstract":"<p><strong>Background: </strong>As the high-risk stage of diabetes, the role of prediabetes in the development of hepatocellular carcinoma (HCC) remains unclear. To address this knowledge gap, we undertook a meta-analysis to investigate the potential association between the prediabetic stage and HCC.</p><p><strong>Methods: </strong>In this study, two independent investigators conducted a comprehensive search for relevant articles published up until May 2023 in several databases, including PubMed, Web of Science, Medline, EMBASE, and Google Scholar. The results were then summarized using STATA 12.0 software.</p><p><strong>Results: </strong>Our analysis included a total of 6 cohort studies involving 1,490,752 participants, as well as 1 case-control study with 220 participants. The research aimed to examine the association between prediabetes and the risk of HCC. Our meta-analysis revealed that prediabetes was significantly associated with an elevated risk of HCC (odds ratio (OR)/relative risk (RR) = 1.25, 95% confidence interval (CI) 1.06 to 1.48, I<sup>2</sup> = 57.2%, <i>p</i> = 0.012), using a random-effects model. Moreover, four cohort studies, encompassing 1,362,847 participants, explored the relationship between prediabetes and HCC mortality. The meta-analysis showed that prediabetes was associated with a higher mortality rate of HCC, also utilizing a random-effects model (hazard ratio (HR) = 1.36, 95% CI 1.02 to 1.81, I<sup>2</sup> = 55.8%, <i>p</i> = 0.060).</p><p><strong>Conclusions: </strong>Overall, our findings highlight a significant association between prediabetes and an increased risk of HCC and suggest that prediabetes may also contribute to higher mortality rates among HCC patients.</p>","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":" ","pages":"186-192"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory Markers in Thyroid Eye Disease: A Meta-Analysis. 甲状腺眼病的炎症标记物:元分析
IF 1.5 4区 医学
Endocrine Research Pub Date : 2024-08-01 Epub Date: 2024-06-13 DOI: 10.1080/07435800.2024.2362787
Shu-Han Chuang, Cheng-Hsien Chang
{"title":"Inflammatory Markers in Thyroid Eye Disease: A Meta-Analysis.","authors":"Shu-Han Chuang, Cheng-Hsien Chang","doi":"10.1080/07435800.2024.2362787","DOIUrl":"10.1080/07435800.2024.2362787","url":null,"abstract":"<p><p>Thyroid Eye Disease (TED) is an inflammatory autoimmune condition affecting the eyes, often associated with Graves' disease. Inflammation is important in TED, involving immune cells and orbital tissues. While inflammatory markers have been studied in other diseases, their role in TED is unclear. We included 734 participants from 5 eligible studies investigated associations between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) and TED. Initial analysis found no significant differences in these markers between TED and control groups. However, sensitivity analysis excluding an outlier study revealed significant differences in NLR, PLR, and MLR between groups, suggesting the potential association between these inflammatory markers and TED. More research is needed, but these findings indicate complex TED pathogenesis and that inflammation may offer insights for TED diagnosis and management.</p>","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":" ","pages":"193-202"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms. 作为肺部和非肺部神经内分泌肿瘤诊断生物标记物的胃泌素释放肽
IF 1.5 4区 医学
Endocrine Research Pub Date : 2024-08-01 Epub Date: 2024-07-23 DOI: 10.1080/07435800.2024.2365895
Anna La Salvia, Giuseppe Fanciulli
{"title":"Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms.","authors":"Anna La Salvia, Giuseppe Fanciulli","doi":"10.1080/07435800.2024.2365895","DOIUrl":"10.1080/07435800.2024.2365895","url":null,"abstract":"<p><strong>Background: </strong>Progastrin-releasing peptide (ProGRP) is the precursor of the gastrin-releasing peptide, a neuropeptide secreted by cells of neural and endocrine origin. Recently, ProGRP has emerged as a circulating biomarker for small cell lung cancer (SCLC), a subtype of aggressive and poorly differentiated neuroendocrine neoplasm (NEN). Given the ability of the neuroendocrine SCLC cells to secrete this peptide, we performed an in-depth narrative review aimed at collecting, summarizing, and critically analyzing the available literature about the possible value of ProGRP as a biomarker for pulmonary NENs other than SCLC, and for NENs of non-pulmonary origin.</p><p><strong>Methods: </strong>We conducted an extensive search on international databases (PubMed, Web of Science, and Scopus).</p><p><strong>Results: </strong>We selected 21 pertinent published articles (12 original studies and 9 case reports). Overall, the original studies included 1,711 patients, and the case reports described the clinical course of 10 patients.</p><p><strong>Conclusion: </strong>The data analyzed suggest a potential role for ProGRP as a diagnostic biomarker for typical and atypical lung carcinoids, pulmonary large cell neuroendocrine carcinoma, medullary thyroid carcinoma, non-pulmonary neuroendocrine carcinomas, prostate cancer with neuroendocrine differentiation, and the pancreatobiliary neuroendocrine carcinoma. Despite these promising results, additional studies are needed, to clarify the role of ProGRP as the diagnostic biomarker for specific NENs.</p>","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":" ","pages":"243-250"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Corticosteroid and Nonsteroid Anti-Inflammatory Therapies on Permanent Hypothyroidism Occurring After the Subacute Thyroiditis 皮质类固醇和非类固醇抗炎疗法对亚急性甲状腺炎后发生的永久性甲状腺功能减退症的影响
IF 2.1 4区 医学
Endocrine Research Pub Date : 2024-04-21 DOI: 10.1080/07435800.2024.2344719
Naile Gokkaya, Kadriye Aydin Tezcan
{"title":"The Effects of Corticosteroid and Nonsteroid Anti-Inflammatory Therapies on Permanent Hypothyroidism Occurring After the Subacute Thyroiditis","authors":"Naile Gokkaya, Kadriye Aydin Tezcan","doi":"10.1080/07435800.2024.2344719","DOIUrl":"https://doi.org/10.1080/07435800.2024.2344719","url":null,"abstract":"Subacute thyroiditis(SAT) is an acute inflammatory, self-limited, and destructive disease of the thyroid gland. Although it is a temporary disease, it has permanent consequences. We aim to investig...","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":"78 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140627232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital Health in Diabetes and Cardiovascular Disease 糖尿病和心血管疾病中的数字健康
IF 2.1 4区 医学
Endocrine Research Pub Date : 2024-04-11 DOI: 10.1080/07435800.2024.2341146
Dorothy Avoke, Abdallah Elshafeey, Robert Weinstein, Chang H. Kim, Seth S. Martin
{"title":"Digital Health in Diabetes and Cardiovascular Disease","authors":"Dorothy Avoke, Abdallah Elshafeey, Robert Weinstein, Chang H. Kim, Seth S. Martin","doi":"10.1080/07435800.2024.2341146","DOIUrl":"https://doi.org/10.1080/07435800.2024.2341146","url":null,"abstract":"Digital health technologies are rapidly evolving and transforming the care of diabetes and cardiovascular disease (CVD).In this review, we discuss emerging approaches incorporating digital health t...","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":"215 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140591133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of in vitro Toxicities of 8-Prenylnaringenin, Tartrazine and 17β-Estradiol, Representatives of Natural and Synthetic Estrogens, in Rat and Human Hepatoma Cell Lines 天然雌激素和合成雌激素的代表--8-异戊烯基柚皮素、酒石酸和 17β-Estradiol 在大鼠和人类肝癌细胞系中的体外毒性比较
IF 2.1 4区 医学
Endocrine Research Pub Date : 2024-04-10 DOI: 10.1080/07435800.2024.2337758
Atefeh Nasri, Raimo Pohjanvirta
{"title":"Comparison of in vitro Toxicities of 8-Prenylnaringenin, Tartrazine and 17β-Estradiol, Representatives of Natural and Synthetic Estrogens, in Rat and Human Hepatoma Cell Lines","authors":"Atefeh Nasri, Raimo Pohjanvirta","doi":"10.1080/07435800.2024.2337758","DOIUrl":"https://doi.org/10.1080/07435800.2024.2337758","url":null,"abstract":"Background: Phytoestrogens have been praised for their beneficial health effects, whereas synthetic xenoestrogens have been connected to ailments. Aims: To ascertain whether the toxicities of natur...","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":"20 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140591294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possible sarcopenia and risk of chronic kidney disease: a four-year follow-up study and Mendelian randomization analysis. 可能的肌肉疏松症与慢性肾脏病风险:一项为期四年的随访研究和孟德尔随机分析。
IF 1.5 4区 医学
Endocrine Research Pub Date : 2024-02-01 Epub Date: 2024-05-13 DOI: 10.1080/07435800.2024.2353842
Yang Xiong, Xue Jiang, Qian Zhong, Yangchang Zhang, Haowen Zhang, Zhihong Liu, Xianding Wang
{"title":"Possible sarcopenia and risk of chronic kidney disease: a four-year follow-up study and Mendelian randomization analysis.","authors":"Yang Xiong, Xue Jiang, Qian Zhong, Yangchang Zhang, Haowen Zhang, Zhihong Liu, Xianding Wang","doi":"10.1080/07435800.2024.2353842","DOIUrl":"10.1080/07435800.2024.2353842","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic kidney disease (CKD) is a common risk factor for sarcopenia. However, whether sarcopenia increases the risk of CKD remains unclear. To investigate the longitudinal and causal associations between possible sarcopenia and CKD, this study was performed.</p><p><strong>Methods: </strong>Possible sarcopenia was defined according to the Asian Working Group for Sarcopenia in 2019. Participants aged ≥ 40 years were recruited from the baseline survey of the China Health and Retirement Longitudinal Study and followed up for four years. Binary logistic regression was used to evaluate the cross-sectional and longitudinal associations between possible sarcopenia, low muscle strength, low physical performance and CKD. Propensity score matching was used to balance the intergroup differences. Subgroup and interactive analyses were adopted to identify potential interactive effects. Mendelian Randomization analysis was used to assess the causal association between appendicular lean mass (ALM) and CKD.</p><p><strong>Results: </strong>After data cleansing, a total of 7296 participants were included in the baseline survey. In the cross-sectional analyses, the odds ratios (ORs) of prevalent CKD were 1.50 (95% CI = 1.23-1.84, <i>p</i> < 0.001) for possible sarcopenia, 1.37 (95% CI = 1.10-1.70, <i>p</i> < 0.01) for low muscle strength and 1.42 (95% CI = 1.16-1.74, <i>p</i> < 0.001) for low physical performance in the full models. No significant interaction effects of covariates were detected (all <i>P</i> for interaction > 0.05). After four years of follow-up, an increased risk of incident CKD was also observed in participants with possible sarcopenia (OR = 1.66, 95% CI = 1.13-2.44, <i>p</i> = 0.010) and low physical performance (OR = 1.69, 95% CI = 1.16-2.45, <i>p</i> = 0.006), but not in participants with low muscle strength (OR = 1.19, 95% CI = 0.75-1.88, <i>p</i> = 0.469). In the Mendelian Randomization analysis, the inverse variance weighted estimator showed that a 1-standard deviation increase of genetically predicted ALM was associated with a lower risk of CKD (OR = 0.92, 95% CI = 0.85-0.99, <i>p</i> = 0.035). All the sensitivity analyses supported the main findings.</p><p><strong>Conclusions: </strong>Possible sarcopenia is an independent risk factor for CKD and may serve as a predictor of CKD for early identification and intervention.</p>","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":" ","pages":"165-178"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140911606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Effectiveness of In-Hospital Exercise Rehabilitation in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus Combined with Sarcopenia Effect of Lifestyle Management on Disease Status in Patients with Type 2 Diabetes Mellitus. 评估院内运动康复对中老年 2 型糖尿病合并肌肉疏松症患者的疗效 生活方式管理对 2 型糖尿病患者病情的影响。
IF 1.5 4区 医学
Endocrine Research Pub Date : 2024-02-01 Epub Date: 2024-05-19 DOI: 10.1080/07435800.2024.2353121
Jianhua Shi, Gaojun Yin, Zhiyun Shi, Shengjun Zhang, Jing Wei, Tao Xue, Xiaoqian Su
{"title":"Evaluation of the Effectiveness of In-Hospital Exercise Rehabilitation in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus Combined with Sarcopenia Effect of Lifestyle Management on Disease Status in Patients with Type 2 Diabetes Mellitus.","authors":"Jianhua Shi, Gaojun Yin, Zhiyun Shi, Shengjun Zhang, Jing Wei, Tao Xue, Xiaoqian Su","doi":"10.1080/07435800.2024.2353121","DOIUrl":"10.1080/07435800.2024.2353121","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to explore the effects of in-hospital exercise rehabilitation on glucose and lipid metabolism and healthy physical fitness in middle-aged and elderly patients with type 2 diabetes mellitus (T2DM) combined with sarcopenia, and to provide a reference for the effective implementation of exercise rehabilitation for middle-aged and elderly patients with T2DM combined with sarcopenia in healthcare institutions.</p><p><strong>Methods: </strong>This study retrospectively included 122 patients with T2DM combined with sarcopenia treated at the General Hospital of Ningxia Medical University from August 2017 to August 2020 and randomly divided into a control group and an experimental group. The control group was given conventional treatment and the experimental group was given exercise rehabilitation in the hospital for 12 weeks to compare the indexes related to glucose and lipid metabolism and healthy fitness in the two groups.</p><p><strong>Results: </strong>After the intervention, the experimental group showed significant decreases in fasting blood glucose (FBG), glycated hemoglobin (HbA1c), insulin resistance index (HOMA-IR), triglycerides (TG), total cholesterol (TC), low-density cholesterol (LDL-C) and body fat percentage (<i>p</i> < 0.05), while high-density cholesterol (HDL-C), grip strength, lower limb extension, lower limb flexion, peak oxygen uptake were significantly higher (<i>p</i> < 0.05) and were more significant at 12 weeks compared to the 6-week intervention (<i>p</i> < 0.05). However, there were no significant changes in any of the glucose metabolism indicators in the control group before and after the intervention. A two-way repeated measures ANOVA showed that at control baseline levels, HbA1c decreased significantly in the experimental group after both 6 and 12 weeks of intervention compared to the control group (<i>p</i> < 0.05). After 6 weeks of intervention, the experimental group showed a significant decrease in body fat percentage and a significant increase in grip strength. After 12 weeks of intervention, the experimental group showed an increase in glycemic control from 33.3% to 73.3%, a significant decrease in body fat percentage and a significant increase in grip strength, lower limb extension and lower limb flexion strength and peak oxygen uptake.</p><p><strong>Conclusion: </strong>In-hospital exercise rehabilitation can effectively improve the glycemic and lipid profiles of patients with T2DM combined with sarcopenia and enhance their health fitness, with good clinical rehabilitation effects.</p>","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":" ","pages":"154-164"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between the Serum α-Klotho Level and Insulin Resistance in Adults: NHANES 2007-2016. 成人血清α-Klotho水平与胰岛素抵抗之间的关系Nhanes 2007-2016.
IF 1.5 4区 医学
Endocrine Research Pub Date : 2024-02-01 Epub Date: 2024-05-09 DOI: 10.1080/07435800.2024.2350428
Yuxiuzi Xiao, Yuanzheng Hou, Jing Zeng, Yanping Gong, Lichao Ma
{"title":"Association Between the Serum α-Klotho Level and Insulin Resistance in Adults: NHANES 2007-2016.","authors":"Yuxiuzi Xiao, Yuanzheng Hou, Jing Zeng, Yanping Gong, Lichao Ma","doi":"10.1080/07435800.2024.2350428","DOIUrl":"10.1080/07435800.2024.2350428","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the relationship between serum α-Klotho levels and insulin resistance (IR), a precursor to type 2 diabetes.</p><p><strong>Methods: </strong>The study analyzed data from 4,758 adult participants in the National Health and Nutrition Examination Survey (NHANES) spanning from 2007 to 2016. The relationship between α-Klotho concentration and IR was assessed using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and odds ratios (OR) derived from logistic regression models.</p><p><strong>Results: </strong>Results showed that every 1-ln increase in α-Klotho concentration raised the HOMA-IR value by 0.55 (95% confidence interval 0.35-0.74) and the odds of IR by 64% (odds ratio 1.64; 95% confidence interval 1.28-2.1). The odds of IR was 40% greater in highest tertile than in the lowest tertile.</p><p><strong>Conclusion: </strong>The findings of this study underscore a significant correlation between increased serum α-Klotho levels and the prevalence of IR.</p>","PeriodicalId":11601,"journal":{"name":"Endocrine Research","volume":" ","pages":"145-153"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书